AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 19, 2026

VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
Oct. 19, 2026

VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity

Indeterminate GlobeNewswire
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
Oct. 19, 2026

TerrAscend to Host Third Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
Oct. 19, 2026

RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation

Indeterminate GlobeNewswire
ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
Oct. 19, 2026

ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates

Indeterminate GlobeNewswire
MDA Announces 2027 Clinical & Scientific Conference Agenda Featuring AI, Gene Therapy, Patient Data and the Latest Neuromuscular Disease Research
Oct. 19, 2026

MDA Announces 2027 Clinical & Scientific Conference Agenda Featuring AI, Gene Therapy, Patient Data and the Latest Neuromuscular Disease Research

Indeterminate GlobeNewswire
Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy
Oct. 19, 2026

Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy

Indeterminate GlobeNewswire
23andMe Research Institute to Showcase Scientific Impact and Expanded Research Capabilities at ASHG 2026
Oct. 19, 2026

23andMe Research Institute to Showcase Scientific Impact and Expanded Research Capabilities at ASHG 2026

Indeterminate GlobeNewswire
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer
Oct. 19, 2026

XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer

Indeterminate GlobeNewswire
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
Oct. 19, 2026

Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer

Indeterminate GlobeNewswire
OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market
Oct. 19, 2026

OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market

Indeterminate GlobeNewswire
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
Oct. 19, 2026

SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications

Indeterminate GlobeNewswire
Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic Health Management
Oct. 19, 2026

Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic Health Management

Indeterminate GlobeNewswire
Decamen App Launches Personalized Military-Style Home Workout Plan for Busy Men
Oct. 19, 2026

Decamen App Launches Personalized Military-Style Home Workout Plan for Busy Men

Indeterminate GlobeNewswire
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Oct. 19, 2026

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

Indeterminate GlobeNewswire
Indivior to Report Third Quarter 2026 Financial Results
Oct. 19, 2026

Indivior to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
Oct. 19, 2026

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

Indeterminate GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
Oct. 19, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine

Indeterminate GlobeNewswire
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
Oct. 19, 2026

Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting

Indeterminate GlobeNewswire
Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
Oct. 19, 2026

Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.

Indeterminate GlobeNewswire
J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area
Oct. 19, 2026

J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.